US-HEALTH-VIRUS

In this photo illustration a Gilead logo is displayed on a smartphone next to a screen showing a coronavirus graphic on March 25, 2020 in Arlington, Virginia. - Gilead announced on March 25, 2020 that it has submitted a request to the Food and Drug Administration to rescind the exclusive marketing rights it had secured for remdesivir, an antiviral drug that shows promise in treating Covid-19, the disease caused by the new coronavirus. (Photo by Olivier DOULIERY / AFP) (Photo by OLIVIER DOULIERY/AFP via Getty Images)
In this photo illustration a Gilead logo is displayed on a smartphone next to a screen showing a coronavirus graphic on March 25, 2020 in Arlington, Virginia. - Gilead announced on March 25, 2020 that it has submitted a request to the Food and Drug Administration to rescind the exclusive marketing rights it had secured for remdesivir, an antiviral drug that shows promise in treating Covid-19, the disease caused by the new coronavirus. (Photo by Olivier DOULIERY / AFP) (Photo by OLIVIER DOULIERY/AFP via Getty Images)
US-HEALTH-VIRUS
LICENTIE KOPEN
Hoe mag ik dit beeld gebruiken?
€ 475,00
EUR

GEGEVENS

Beperkingen:
Neem voor gebruik voor alle commerciële of promotiedoeleinden contact op met uw lokale kantoor. Volledige redactionele rechten in het Verenigd Koninkrijk, de Verenigde Staten, Ierland, Italië, Spanje en Canada (behalve Québec). Beperkte redactionele rechten in andere delen van de wereld. Bel ons lokale kantoor voor meer informatie hierover.
Credits:
OLIVIER DOULIERY / Contributor
Redactioneel nr.:
1208237136
Collectie:
AFP
Gemaakt op:
25 maart 2020
Datum van uploaden:
Soort licentie:
Release-informatie:
Geen release. Meer informatie
Bron:
AFP
Barcode:
AFP
Naam materiaal:
AFP_1Q67SP
Max. bestandsgrootte:
4000 x 2507 px (33,87 x 21,23 cm) - 300 dpi - 2 MB